| pubmed-article:11163497 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11163497 | lifeskim:mentions | umls-concept:C1516213 | lld:lifeskim |
| pubmed-article:11163497 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
| pubmed-article:11163497 | lifeskim:mentions | umls-concept:C1457887 | lld:lifeskim |
| pubmed-article:11163497 | lifeskim:mentions | umls-concept:C0034380 | lld:lifeskim |
| pubmed-article:11163497 | lifeskim:mentions | umls-concept:C0032659 | lld:lifeskim |
| pubmed-article:11163497 | lifeskim:mentions | umls-concept:C0021853 | lld:lifeskim |
| pubmed-article:11163497 | lifeskim:mentions | umls-concept:C0005682 | lld:lifeskim |
| pubmed-article:11163497 | lifeskim:mentions | umls-concept:C0205307 | lld:lifeskim |
| pubmed-article:11163497 | lifeskim:mentions | umls-concept:C0600521 | lld:lifeskim |
| pubmed-article:11163497 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:11163497 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
| pubmed-article:11163497 | lifeskim:mentions | umls-concept:C0205087 | lld:lifeskim |
| pubmed-article:11163497 | lifeskim:mentions | umls-concept:C0450363 | lld:lifeskim |
| pubmed-article:11163497 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:11163497 | pubmed:dateCreated | 2001-2-22 | lld:pubmed |
| pubmed-article:11163497 | pubmed:abstractText | The goals of this study were twofold. First, differences were quantified for symptoms that impact bowel and bladder quality of life (QOL) in prostate cancer patients treated with three-dimensional conformal radiotherapy (3DCRT) alone to the prostate vs. whole pelvis with prostate boost. Second, bowel and bladder QOL measures for these patients were compared to those of the normal population of men with a similar age distribution. | lld:pubmed |
| pubmed-article:11163497 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11163497 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11163497 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11163497 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11163497 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11163497 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:11163497 | pubmed:issn | 0360-3016 | lld:pubmed |
| pubmed-article:11163497 | pubmed:author | pubmed-author:PeterRR | lld:pubmed |
| pubmed-article:11163497 | pubmed:author | pubmed-author:HanksG EGE | lld:pubmed |
| pubmed-article:11163497 | pubmed:author | pubmed-author:HanlonA LAL | lld:pubmed |
| pubmed-article:11163497 | pubmed:author | pubmed-author:Watkins... | lld:pubmed |
| pubmed-article:11163497 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11163497 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:11163497 | pubmed:volume | 49 | lld:pubmed |
| pubmed-article:11163497 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11163497 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11163497 | pubmed:pagination | 51-9 | lld:pubmed |
| pubmed-article:11163497 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:11163497 | pubmed:meshHeading | pubmed-meshheading:11163497... | lld:pubmed |
| pubmed-article:11163497 | pubmed:meshHeading | pubmed-meshheading:11163497... | lld:pubmed |
| pubmed-article:11163497 | pubmed:meshHeading | pubmed-meshheading:11163497... | lld:pubmed |
| pubmed-article:11163497 | pubmed:meshHeading | pubmed-meshheading:11163497... | lld:pubmed |
| pubmed-article:11163497 | pubmed:meshHeading | pubmed-meshheading:11163497... | lld:pubmed |
| pubmed-article:11163497 | pubmed:meshHeading | pubmed-meshheading:11163497... | lld:pubmed |
| pubmed-article:11163497 | pubmed:meshHeading | pubmed-meshheading:11163497... | lld:pubmed |
| pubmed-article:11163497 | pubmed:meshHeading | pubmed-meshheading:11163497... | lld:pubmed |
| pubmed-article:11163497 | pubmed:meshHeading | pubmed-meshheading:11163497... | lld:pubmed |
| pubmed-article:11163497 | pubmed:meshHeading | pubmed-meshheading:11163497... | lld:pubmed |
| pubmed-article:11163497 | pubmed:meshHeading | pubmed-meshheading:11163497... | lld:pubmed |
| pubmed-article:11163497 | pubmed:meshHeading | pubmed-meshheading:11163497... | lld:pubmed |
| pubmed-article:11163497 | pubmed:meshHeading | pubmed-meshheading:11163497... | lld:pubmed |
| pubmed-article:11163497 | pubmed:meshHeading | pubmed-meshheading:11163497... | lld:pubmed |
| pubmed-article:11163497 | pubmed:meshHeading | pubmed-meshheading:11163497... | lld:pubmed |
| pubmed-article:11163497 | pubmed:meshHeading | pubmed-meshheading:11163497... | lld:pubmed |
| pubmed-article:11163497 | pubmed:meshHeading | pubmed-meshheading:11163497... | lld:pubmed |
| pubmed-article:11163497 | pubmed:meshHeading | pubmed-meshheading:11163497... | lld:pubmed |
| pubmed-article:11163497 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11163497 | pubmed:articleTitle | Quality of life study in prostate cancer patients treated with three-dimensional conformal radiation therapy: comparing late bowel and bladder quality of life symptoms to that of the normal population. | lld:pubmed |
| pubmed-article:11163497 | pubmed:affiliation | Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA. AL_Hanlon@FCCC.edu | lld:pubmed |
| pubmed-article:11163497 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11163497 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:11163497 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:11163497 | pubmed:publicationType | Review | lld:pubmed |
